The Impact of a Mobile Diabetes Health Intervention on Diabetes Distress and Depression Among Adults: Secondary Analysis of a Cluster Randomized Controlled Trial

Charlene C Quinn, Krystal K Swasey, J Christopher F Crabbe, Michelle D Shardell, Michael L Terrin, Erik A Barr, Ann L Gruber-Baldini, Charlene C Quinn, Krystal K Swasey, J Christopher F Crabbe, Michelle D Shardell, Michael L Terrin, Erik A Barr, Ann L Gruber-Baldini

Abstract

Background: Diabetes is a complex, demanding disease that requires the constant attention of patients. The burden of self-management, including different medication regimens, routine self-care activities, and provider visits, has an impact on patients' emotional well-being. Diabetes distress and depression are two important components of emotional well-being that may negatively affect diabetes outcomes.

Objective: The aim was to determine the impact of the 1-year Mobile Diabetes Intervention Study cluster randomized clinical trial on emotional well-being measured by diabetes distress and depression among adults with type 2 diabetes (T2D).

Methods: A total of 163 adults with not-well-managed T2D were enrolled from community primary care practices. Primary care practices were cluster randomized into either a usual care control group or intervention group. Intervention participants were given a mobile phone with coaching software including a Web portal to communicate with providers. A priori established secondary outcomes included distress measured by the Diabetes Distress Scale (DDS), with subscales measuring emotional burden, interpersonal distress, physician-related distress, and regimen-related distress, as well as depression measured by the Patient Health Questionnaire (PHQ-9). Linear mixed models were used to calculate the effect of the intervention on diabetes distress levels over time, both overall and separately by sex, and to determine if the intervention affected distress or depression. The impact of total DDS on changes in HbA1c was also studied.

Results: There were no significant treatment group effects for DDS total (baseline: P=.07; differences over time: P=.38) or for depression (P=.06 over time). Significant declines in total DDS were observed over the 12-month intervention period (P=.01). Regimen-related distress significantly decreased for all study participants (P<.001), but no significant change over time was observed for emotional burden (P=.83), interpersonal distress (P=.64), or physician-related distress (P=.73). Women in both the usual care and intervention groups were more likely to have higher overall DDS, emotional burden, physician-related distress, and regimen-related distress, but not interpersonal distress. Women also reported higher baseline depression compared to men (P=.006). Overall, depression decreased over the treatment period (P=.007), but remained unaffected by group assignment (P=.06) or by sex (P=.97). Diabetes distress had no effect on the change in HbA1c (P=.91) over the treatment period.

Conclusions: Although we found no definitive overall or sex-specific effect of the intervention on diabetes distress or depression, this study makes an important contribution to the understanding of mobile health interventions and the impact on emotional health. Our study verified previous work that although diabetes distress and depression are highly correlated, these measures are not evaluating the same construct. Design of future mobile technology provides an opportunity to personalize, contextualize, and intervene in the emotional well-being of persons with diabetes.

Trial registration: Clinicaltrials.gov NCT01107015; https://ichgcp.net/clinical-trials-registry/NCT01107015 (Archived by WebCite at http://www.webcitation.org/6vVgRCLAF).

Keywords: Diabetes Distress Scale; Patient Health Questionnaire; depression; diabetes; diabetes distress; emotional well-being; mobile health; women.

Conflict of interest statement

Conflicts of Interest: None declared.

©Charlene C Quinn, Krystal K Swasey, J Christopher F Crabbe, Michelle D Shardell, Michael L Terrin, Erik A Barr, Ann L Gruber-Baldini. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 07.12.2017.

Figures

Figure 1
Figure 1
Mean and standard deviation for the change in total Diabetes Distress Scale scores from baseline to 12 months for control (n=46-56) and intervention (n=57-58) groups. Whiskers represent standard deviation.
Figure 2
Figure 2
Mean and standard deviation for the change in Diabetes Distress Scale subscale scores from baseline to 12 months for control (n=46-56) and intervention (n=57-58) groups. Whiskers represent standard deviation.

References

    1. Centers for Disease Control and Prevention National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. 2017. .
    1. Centers for Disease Control and Prevention National Diabetes Fact Sheet, 2011. 2011. .
    1. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Cowie CC, Gregg EW. Secular changes in the age-specific prevalence of diabetes among US adults: 1988-2010. Diabetes Care. 2013 Sep;36(9):2690–2696. doi: 10.2337/dc12-2074.
    1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010 Oct 22;8:29. doi: 10.1186/1478-7954-8-29.
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393–403. doi: 10.1056/NEJMoa012512.
    1. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008 May 24;371(9626):1783–1789. doi: 10.1016/S0140-6736(08)60766-7.
    1. Tran V. Minimally Disruptive Medicine [blog] 2015. Jun 29, Burden of treatment: the work of being a patient .
    1. Leppin AL, Montori VM, Gionfriddo MR. Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. Healthcare (Basel) 2015 Jan 29;3(1):50–63. doi: 10.3390/healthcare3010050.
    1. Polonsky W. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum. 2000;13:36.
    1. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997 May;20(5):760–766.
    1. Gonzalez JS, Fisher L, Polonsky WH. Depression in diabetes: have we been missing something important? Diabetes Care. 2011 Jan;34(1):236–239. doi: 10.2337/dc10-1970.
    1. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015 Jun;3(6):450–460. doi: 10.1016/S2213-8587(15)00135-7.
    1. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med. 2008 Sep;25(9):1096–1101. doi: 10.1111/j.1464-5491.2008.02533.x.
    1. Pandit AU, Bailey SC, Curtis LM, Seligman HK, Davis TC, Parker RM, Schillinger D, DeWalt D, Fleming D, Mohr DC, Wolf MS. Disease-related distress, self-care and clinical outcomes among low-income patients with diabetes. J Epidemiol Community Health. 2014 Jun;68(6):557–564. doi: 10.1136/jech-2013-203063.
    1. Fisher L, Mullan JT, Skaff MM, Glasgow RE, Arean P, Hessler D. Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study. Diabet Med. 2009 Jun;26(6):622–627. doi: 10.1111/j.1464-5491.2009.02730.x.
    1. Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N. How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS) Diabet Med. 2016 Jun;33(6):835–843. doi: 10.1111/dme.12887.
    1. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–252. doi: 10.1370/afm.842.
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001 Jun;24(6):1069–1078.
    1. Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015 Apr;75(6):577–587. doi: 10.1007/s40265-015-0347-4.
    1. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002 Mar;25(3):464–470.
    1. Winchester RJ, Williams JS, Wolfman TE, Egede LE. Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes. J Diabetes Complications. 2016 Mar;30(2):312–317. doi: 10.1016/j.jdiacomp.2015.11.010.
    1. Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ. Tangled up in blue: unraveling the links between emotional distress and treatment adherence in type 2 diabetes. Diabetes Care. 2016 Dec;39(12):2182–2189. doi: 10.2337/dc16-1657.
    1. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000 Nov 27;160(21):3278–3285.
    1. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, Glasgow R, Laurencin G. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007 Mar;30(3):542–548. doi: 10.2337/dc06-1614.
    1. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005 Mar;28(3):626–631.
    1. Arnhold M, Quade M, Kirch W. Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res. 2014;16(4):e104. doi: 10.2196/jmir.2968.
    1. Clarke J, Proudfoot J, Ma H. Mobile phone and web-based cognitive behavior therapy for depressive symptoms and mental health comorbidities in people living with diabetes: results of a feasibility study. JMIR Ment Health. 2016 May 31;3(2):e23. doi: 10.2196/mental.5131.
    1. Wayne N, Perez DF, Kaplan DM, Ritvo P. Health coaching reduces HbA1c in type 2 diabetic patients from a lower-socioeconomic status community: a randomized controlled trial. J Med Internet Res. 2015;17(10):e224. doi: 10.2196/jmir.4871.
    1. Kitsiou S, Paré G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews. PLoS One. 2017;12(3):e0173160. doi: 10.1371/journal.pone.0173160.
    1. Wu Y, Yao X, Vespasiani G, Nicolucci A, Dong Y, Kwong J, Li L, Sun X, Tian H, Li S. Mobile app-based interventions to support diabetes self-management: a systematic review of randomized controlled trials to identify functions associated with glycemic efficacy. JMIR Mhealth Uhealth. 2017 Mar 14;5(3):e35. doi: 10.2196/mhealth.6522.
    1. Hunt CW. Technology and diabetes self-management: an integrative review. World J Diabetes. 2015 Mar 15;6(2):225–233. doi: 10.4239/wjd.v6.i2.225.
    1. Fisher L, Hessler D, Glasgow RE, Arean PA, Masharani U, Naranjo D, Strycker LA. REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care. 2013 Sep;36(9):2551–2558. doi: 10.2337/dc12-2493.
    1. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS. Diabetes in older adults. Diabetes Care. 2012 Dec;35(12):2650–2664. doi: 10.2337/dc12-1801.
    1. Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, Terrin M, Bronich-Hall L, Barr E, Lender D. Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemp Clin Trials. 2009 Jul;30(4):334–346. doi: 10.1016/j.cct.2009.02.004.
    1. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934–1942. doi: 10.2337/dc11-0366.
    1. Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile diabetes intervention for glycemic control: impact on physician prescribing. J Diabetes Sci Technol. 2014 Mar;8(2):362–370. doi: 10.1177/1932296813514503.
    1. Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012 Feb;35(2):259–264. doi: 10.2337/dc11-1572.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–613.
    1. Tran V, Barnes C, Montori VM, Falissard B, Ravaud P. Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions. BMC Med. 2015 May 14;13:115. doi: 10.1186/s12916-015-0356-x.
    1. Hessler D, Fisher L, Glasgow RE, Strycker LA, Dickinson LM, Arean PA, Masharani U. Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care. 2014;37(3):617–624. doi: 10.2337/dc13-0762.
    1. Spring B, Schneider K, McFadden HG, Vaughn J, Kozak AT, Smith M, Moller AC, Epstein LH, Demott A, Hedeker D, Siddique J, Lloyd-Jones DM. Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology. Arch Intern Med. 2012 May 28;172(10):789–796. doi: 10.1001/archinternmed.2012.1044.
    1. Fonda SJ, McMahon GT, Gomes HE, Hickson S, Conlin PR. Changes in diabetes distress related to participation in an internet-based diabetes care management program and glycemic control. J Diabetes Sci Technol. 2009 Jan;3(1):117–124.
    1. Nicolucci A, Kovacs BK, Holt RI, Comaschi M, Hermanns N, Ishii H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M, DAWN2 SG. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013 Jul;30(7):767–777. doi: 10.1111/dme.12245.
    1. Kovacs BK, Nicolucci A, Holt RI, Willaing I, Hermanns N, Kalra S, Wens J, Pouwer F, Skovlund SE, Peyrot M, DAWN2 Study Group Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med. 2013 Jul;30(7):778–788. doi: 10.1111/dme.12239.
    1. Funnell M. Beyond the data: moving towards a new DAWN in diabetes. Diabet Med. 2013 Jul;30(7):765–766. doi: 10.1111/dme.12244.
    1. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016 Dec;99(6):926–943. doi: 10.1016/j.pec.2015.11.003.
    1. Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, Cypress M, Faulkner P, Fischl AH, Francis T, Kolb LE, Lavin-Tompkins JM, MacLeod J, Maryniuk M, Mensing C, Orzeck EA, Pope DD, Pulizzi JL, Reed AA, Rhinehart AS, Siminerio L, Wang J, 2017 Standards Revision Task Force 2017 National standards for diabetes self-management education and support. Diabetes Care. 2017 Oct;40(10):1409–1419. doi: 10.2337/dci17-0025.
    1. Spruijt-Metz D, O'Reilly GA, Cook L, Page KA, Quinn C. Behavioral contributions to the pathogenesis of type 2 diabetes. Curr Diab Rep. 2014 Apr;14(4):475. doi: 10.1007/s11892-014-0475-3.
    1. Anderson RM, Funnell MM. Patient empowerment: myths and misconceptions. Patient Educ Couns. 2010 Jun;79(3):277–282. doi: 10.1016/j.pec.2009.07.025.
    1. Goodwin RD, Friedman HS. Health status and the five-factor personality traits in a nationally representative sample. J Health Psychol. 2006 Sep;11(5):643–654. doi: 10.1177/1359105306066610.
    1. Robertson SM, Stanley MA, Cully JA, Naik AD. Positive emotional health and diabetes care: concepts, measurement, and clinical implications. Psychosomatics. 2012 Jan;53(1):1–12. doi: 10.1016/j.psym.2011.09.008.
    1. Dall TM, Yang W, Halder P, Franz J, Byrne E, Semilla AP, Chakrabarti R, Stuart B. Type 2 diabetes detection and management among insured adults. Popul Health Metr. 2016;14:43. doi: 10.1186/s12963-016-0110-4.
    1. Nelson LA, Mulvaney SA, Gebretsadik T, Ho Y, Johnson KB, Osborn CY. Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes. J Am Med Inform Assoc. 2016 Jan;23(1):12–18. doi: 10.1093/jamia/ocv082.
    1. Nelson LA, Mulvaney SA, Johnson KB, Osborn CY. mHealth intervention elements and user characteristics determine utility: a mixed-methods analysis. Diabetes Technol Ther. 2017 Jan;19(1):9–17. doi: 10.1089/dia.2016.0294.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe